Drug profile · INN
influenza mrna vaccine
MCOMBRIAX
influenza mrna vaccine (MCOMBRIAX) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH.
EMA: approved Antiinfectives for systemic use (J07) J07B
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — influenza mrna vaccine
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
influenza mrna vaccine (MCOMBRIAX) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH.
Key facts
INN influenza mrna vaccine
Brand MCOMBRIAX
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07B
Originator Teva Pharma GmbH
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is influenza mrna vaccine?
influenza mrna vaccine (MCOMBRIAX) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH.
What is the brand name for influenza mrna vaccine?
MCOMBRIAX is a marketed brand name for influenza mrna vaccine. Check FDA Drugs@FDA for the current US label holder and prescribing information.